Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure

NCT07442448 is registered in ClinicalTrials.gov with Cathay General Hospital as lead sponsor.

NCT NCT07442448
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07442448 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure
Lead sponsor
Cathay General Hospital
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
April 30, 2026
Completion date
December 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure, heart failure and mildly reduced ejection fraction, heart failure and preserved ejection fraction